IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients - Wikidata - awgldk - TriplyDB

IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients

IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients

http://www.wikidata.org/entity/Q36541206

about

Hepatitis C genotype 4: The past, present, and future IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.Characterization of the Interleukin-28B Gene rs12979860 C/T Polymorphism in Turkish Chronic Hepatitis C Patients and Healthy Individuals.Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta-analysis.Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey.Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients.Impact of Interleukin 28B Genotype on the Virological Responses in Chronic Hepatitis C Treatment.Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro.

P2860

Q26775815-ED1308E1-A3FA-4E62-8733-7BE61C163863 Q35124008-3BC1B663-798E-4AE1-BBA4-0EBA77E571C4 Q35609162-E0CDA9C0-E6A8-43C7-86BC-EE25B422B8E1 Q35743221-CE355FDC-CC6C-4274-8550-4B042FF83AD4 Q35835981-42F83AF1-5C84-4B46-8DEE-30670AAA3102 Q36004897-F9822121-DB72-4689-8649-4D40C3CDC07E Q36975036-638A489B-FB16-444B-8845-B984C0B6FFA8 Q37242781-E4BB3390-1739-4234-8FC8-5B5AF5D99A5C Q37292899-81F5F933-77D2-4133-BD9D-BF7779E84145 Q37608679-A9C4F5AF-BFA9-4C7F-B3B5-26235AE69F49 Q42257920-B63E6063-EECB-492C-8FCC-ACA82F83ED3B

P2860

IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients

http://www.wikidata.org/entity/Q36541206

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@ast

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@en

type

label

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@ast

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@en

prefLabel

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@ast

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@en

P1433

Q36541206-B11182D5-394A-4980-B72E-8BB048F8EED0

P1476

Q36541206-28A6BAC2-79B2-444D-AAB7-AE18F857F190

P2093

Q36541206-40C68514-A374-4668-B637-5D7FD85E061C

Q36541206-4C292D37-8AF5-40C8-AD85-8F7639B3555E

Q36541206-74E94606-2B4A-43F5-BB13-800BB06651A8

Q36541206-998B9161-AE34-477E-87A9-AEA103001A65

Q36541206-C5146A2C-B546-47BD-8151-518C8789EB44

Q36541206-CD11996B-793C-41AB-899C-5B4DDE4F88C9

Q36541206-E6A0D8FE-9A43-453C-AAD9-69C18596CD55

Q36541206-F61553A2-CC6A-4A35-8A4E-C00461EFE97B

P2860

Q36541206-03F517AA-C254-4C4F-9340-F61D644AB099

Q36541206-18BF0FB0-A6BD-4A13-B7B1-4CD289E3B5F8

Q36541206-1A80FC86-8152-44A8-BC6F-B9BB9B90123D

Q36541206-1AD9C54F-C08B-44A4-ADCB-9EB4C8EB99DF

Q36541206-1E5DA252-4C64-49BB-A05B-5BF5BC3D854B

Q36541206-2296B84D-1B85-418A-A3AD-699AC92B72D2

Q36541206-31B4A382-C7F7-45FE-AFFC-9F03A01BC87E

Q36541206-3B64FED9-207D-415E-A02C-A825A469AAFF

Q36541206-3D1C7965-7BA3-46A6-A270-6F30A4BCC3BA

Q36541206-3DC2E590-0E0C-4DC9-A940-461389813EE9

P304

Q36541206-3B425F73-EE5C-4F1D-966B-1D58F110DD8B

P31

Q36541206-DD7A059E-89DD-4783-8D3D-2BA629E75D50

P356

Q36541206-0ED79CF1-A069-435D-82B0-6B6704502B03

P407

Q36541206-E61873B2-46A8-47BC-9F78-27F1D6BEB8C3

P433

Q36541206-A2BF9CD2-5C85-4AF6-B07D-1430BAD31BB3

P478

Q36541206-E6177502-9D50-4439-A20C-D52F5222BF5D

P577

Q36541206-37E4C52C-B43E-49B6-82EF-E516446EBCAF

P5875

Q36541206-40E5DAD0-4421-4FB6-B6CB-52D5F35B4956

P698

Q36541206-7E89E28D-A812-4A6A-A63E-0616D2141373

P921

Q36541206-4E40FDD4-F8FA-465E-9D7C-91AF3E19A0A6

P932

Q36541206-84127EA3-7029-4E81-9CEB-3B716E40BC5C

P356

P1433

World Journal of Gastroenterology

P1476

IL28B polymorphism and cytomeg ...... n Egyptian HCV type 4 patients

@en

P2093

Ashraf O Abdel Aziz

http://www.w3.org/2001/XMLSchema#string

Ashraf Tabll

http://www.w3.org/2001/XMLSchema#string

Hesham El Khayat

http://www.w3.org/2001/XMLSchema#string

Mohsen Salama

http://www.w3.org/2001/XMLSchema#string

Mostafa K El Awady

http://www.w3.org/2001/XMLSchema#string

Noha G Bader El Din

http://www.w3.org/2001/XMLSchema#string

Tawfeek H Abdelhafez

http://www.w3.org/2001/XMLSchema#string

Yaser El Hosary

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Expert opinion on the treatment of patients with chronic hepatitis C

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

P304

290-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I2.290

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235368499

http://www.w3.org/2001/XMLSchema#string

P698

23345953

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

3547570

http://www.w3.org/2001/XMLSchema#string